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Summary
B7-2 is a recently discovered, second ligand for the CTLA-4/CD28, T cell signaling system.
Using the GL-1 rat monoclonal antibody (mAb), we monitored expression of B7-2 on mouse
leukocytes with an emphasis on dendritic cells. By cytofluorography, little or no B7-2 was detected on most cell types isolated from spleen, thymus, peritoneal cavity, skin, marrow, and blood.
However, expression of B7-2 could be upregulated in culture. In the case of epidermal and spleen
dendritic cells, which become highly immunostimulatory for T cells during a short period of
culture, the upregulation of B7-2 was dramatic and did not require added stimuli. Lipopolysaccharide did not upregulate B7-2 levels on dendritic cells, in contrast to macrophages and B cells.
By indirect immunolabeling, the level of staining with GL-1 mAb exceeded that seen with rat
mAbs to several other surface molecules including intercellular adhesion molecule 1, B7-1, CD44,
and CD45, as well as new hamster mAbs to CD40, CD48, and B7-1/CD80. Of these accessory
molecules, B7-2 was a major species that increased in culture, implying a key role for B7-2 in
the functional maturation of dendritic cells. B7-2 was the main (>90%) CTLA-4 ligand on
mouse dendritic cells. When we applied GL-1 to tissue sections of a dozen different organs,
clear-cut staining with B7-2 antigen was found in many. B7-2 staining was noted on liver Kupffer
cells, interstitial cells of heart and lung, and profiles in the submucosa of the esophagus. B7-2
staining was minimal in the kidney and in the nonlymphoid regions of the gut, and was not
observed at all in the brain. In the tongue, only rare dendritic cells in the oral epithelium were
B7-2 + , but reactive cells were scattered about the interstitial spaces of the muscle. In all lymphoid tissues, GI-1 strongly stained certain distinct regions that are occupied by dendritic cells
and by macrophages. For dendritic cells, these include the thvmic medulla, splenic periarterial
sheaths, and lymph node deep cortex; for macrophages, the B7-2-rich regions included the splenic
marginal zone and lymph node subcapsular cortex. Splenic B7-2 + cells were accessible to labeling
with GL-1 mAb given intravenously. Dendritic cell stimulation of T cells (DNA synthesis) during
the mixed leukocyte reaction was significantly (35-65%) blocked by GL-1. The block could
be enhanced by adding 1G10 anti-B7-1 or by using CTLA-4 Ig, a ligand for both B7-1 and
B7-2. We conclude that B7-2, like other accessory molecules, is expressed by many types of
antigen-presenting cells. However, the regulation and extent of B7-2 expression seems to differ
among cell types. Dendritic cells express very high levels, in several sites in vivo and after maturation into strong accessory cells in culture.
D28 and CTLA-4 are closely related molecules (1, 2)
that are expressed on most T cells. CD28 was first
C
identified using monoclonals that were comparably mitogenic
to anti-TCR mAbs, when administered together with PMA
1849

(3-5). The simultaneous triggering of CD28/CTLA-4 and
CD3/TCR, without PMA, is sufficient to stimulate strong
T cell proliferative responses (6-13). The costimulation
provided via CD28CTLA-4 operates at the level of height-
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Materials and Methods
Mice. BALB/c, (BALB/C x DBA/2) F1, C3H (HeSlc, HeJ,
and HeN) 8-wk-old female mice were purchased from Japan SLC
(Hamamatsu, Shizuoka, Japan). (BALB/C x DBA/2)F1 (Taconic
Farms Inc., Germantown, NY), (BALB/C x C57BL/6)F1 (The
Jackson Laboratory, Bar Harbor, ME), and (C57BL/6 x
DBA/2)F1 (Trudeau Institute, Saranac Lake, NY) mice were also
used,
Cell Suspensions. Cell suspensions from spleen, thymus, lymph
node, blood, marrow, skin, and peritoneal cavity were studied immediately upon isolation or after a period of culture. The medium
was RPMI-1640 supplemented with 5% FCS, 50/~M 2-ME, and
20/zg/ml gentamicin. In some cases, LPS was added as a stimulus
to upregulate expression of B7 and other accessorymolecules. Peritoneal, spleen (32), and epidermal (33) suspensions were cultured
in bulk, and then the component B cells, macrophages, and dendritic cells were identified with select mAbs as indicated below and
in Results. Dendritic cells also were derived from bone marrow
progenitors by culture in rGM-CSF as described (34).
Cytofluorography. A panel ofmAbs was selected to identify several molecular species that contribute to APC function, especially
the APC-T cell interaction. The rat anti-mouse mAbs were directed
to anti-B7-2 (GL-1 [22]); ICAM-1/CD54 (YN1/1.7.4; American
Type Culture Collection [ATCC], Rockville, MD, #CRL1878); heat
i Abbreviation used in thispaper: ICAM-1, intercellularadhesionmolecule1.
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stable antigen (HSA) (M1/69.16.11, ATCC TIB125); MHC class
II (B21-2, ATCC TIB229, and M5/114, ATCC TIB120); B7-1 (1G10
[35]); pgp-1/CD44 (2D2C [36]); CD45 (M1/9.3.4; ATCC TIB122);
NLDC-145 (anti-dendritic cell [37]); B220 (R.A3-6B2 [38]); macrophage sialoadhesin (SER-4 [39]); and 110-10, a nonreactive IgG2a
isotype control All the rat mAbs except the anti-class II reagents
are IgG2as. The hamster anti-mouse mAbs were directed to MHC
class II (N22, ATCC HB225); CD48 (HM48-1 [40]) CD40 (HM403, to be described elsewhere by Yagita, H. et al., raised by immunizing Armenian hamsters with WEHI 231 cells and screening
for reactivity with CHO cells transfected with mouse CD40
cDNA); B7-1/CDS0 (16-10A1 [21] and HMB7, to be described
elsewhere by Azuma, M. et al. and raised by immunizing Armenian hamsters with P815 cells transfected with mouse B7 cDNA).
Biotin-modified mouse anti-Iaa (mouse IgG2b) was from PharMingen (San Diego, CA), and control rat IgG2a and hamster Ig
were from Jackson ImmunoResearchLaboratories(West Grove,PA).
Primary mAbs were applied at saturating levels either as hybridoma supernatants or as pure Igs (1/zg/ml GL-1 and 1G10) to
cells for 30 min in PBS-1%, FCS-0.02% azide on ice, washed, stained
with FITC-mouse anti-rat Ig (FITC-MAR; Boehringer Mannheim
Biochemicals, Indianapolis, IN) for 30 min on ice. Normal rat Ig
was added at 500/~g/ml to quench, and then populations were
stained with a secondmAb to identify specificcell types. The second
mAbs were either biotin anti-B220 (B cells [38]; Pharmigen), biotin anti-MHC class II (Pharmingen), biotin N418 anti-CDllc (dendritic cells [41, 42]; Endogen, Inc., Boston, MA), PE-anti TCRct/B or PE-antiRB6-SC5 (T cells and granulocytes; Pharmingen).
PE-streptavidin was from Tago, Inc. (Burlingame, CA). For staining
with CTLA-4 human Ig fusion protein, 10 #g/ml followedby FITC
anti-human Ig was used, with CD7 human Ig or polyclonalhuman
IgG1 as controls.
T Cell Stimulation. T cellswere purified from mixtures of spleen
and lymph node by passage over nylon wool plus treatment with
anti-MHC class II, anti-B220, and J11d monoclonals plus rabbit
complement. T cells were added at a dose of 3 x 10s (allogeneic
MLR, syngeneic MLR, and Mls responses) or 2 x 105 (stimulation with 2Cll hamster anti-mouse CD3 hybridoma supematant
at 5% vol/vol) in flat-bottomed microtest wells (Nunc, Naperville
IL; Corning, Coming, NY). The stimulator cells were either adherent spleen cells or LPS-stimulated B cells that had been cultured overnight before use and were treated with mitomycin-C (40
/zg/ml for 30 min at 37~
To measure DNA synthesis,
[3H]thymidine was added at 4 /~Ci/ml or 148 KBq/ml (222
GBq/mmol, American Radiolabeled Chemicals, Inc., St. Louis,
MO; 183 GBq/mmol, New England Nuclear, Boston, MA) at
36-48 h (anti-CD3) and 84-96 h (MLR. and Mls). To measure IL-2
release, aliquots of culture supernatant were assayedby ELISA (Endogen, Inc.).
Immunocytochemistry. Organs were removed and immediately
frozen in OCT medium. Cryostat sections were cut at 10/zm and
applied to 10-well multiwell slides (Carlson Scientific Inc., Peotone, IL). The sections could be stored at -20~ or stained immediately. The slides were fixed in absolute acetone for 10 min,
rinsed in PBS, and stained with mAbs followed by peroxidaseconjugated F(ab')2 donkey anti-rat Ig (Jackson ImmunoResearch
Laboratories). Diaminobenzidinewas the chromogen. In some cases,
the sections were counterstained with Gill's hematoxylin (Fisher
Scientific, Fair Lawn, NJ). Severalexperiments were first performed
using lymphoid tissues (spleen and thymus primarily), and then
a systematic tour of 12 different organs (see Results) was done in
two mice.
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ened IL-2 m R N A levels, either by increased transcription (14,
15) or m R N A stability (16).
Initially, the B7/BB1 molecule was identified as the ligand
for CD28 and CTLA-4. It is now evident that there are at
least two ligands, the original B7-1 or CD80 (2, 10, 17-21)
and the newly recognized B7-2 (22-26). These molecules,
when expressed by antigen-presenting B cells or by transfection into cell lines, markedly enhance the capacity of the APC
to induce the production of IL-2 from T cells.
Early on it was realized that strong T cell growth factor
production was especially characteristic of responses that could
be elicited by antigen-presenting, dendritic cells (27, 28). Dendritic cells were found to be reactive with reagents that bind
to BB1 and B7-1 (29-31, and Pope, M., M. Betjes, H. Hirmand, L. Hoffman, and R. M. Steinman, manuscript submitted for publication), and accessory function was reduced
either by soluble CTLA-4 Ig fusion protein (6) or by antiCD28 mAb (29). The possibility of B7-2 expression must
now be evaluated on dendritic cells and on other primary
populations.
Here we describe indirect immunolabeling evidence that
B7-2 is abundant on dendritic cells, apparently more abundant
than most other known surface molecules such as B7-1/CD80,
intercellular adhesion molecule 1 (ICAM-1)t/CD54, LFA-3
equivalent/CD48, CD40, and CD44. No other leukocyte
in culture expresses such high levels of B7-2 as the fully mature dendritic cell, whereas B7-1 is much less abundant. Immunocytochemical studies for B7-2 expression in many
different organs indicate that this costimulator is expressed
at high levels on many populations of macrophages and dendritic cells in situ.
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Results

B7-2 Expression on Isolated Leuteocytes: Cytofluorography.

To

gain information on the tissue distribution of the new B7-2
costimulator, especially on immunostimulatory dendritic cells,
we utilized the mAb GL-1 that has been raised to this molecule (22). Spleen was studied first since this organ is the most
frequently used for analyzing the immune functions of mouse
leukocytes, including dendritic cells. To enrich for the trace
subset of dendritic cells, a fraction with a low buoyant density (5-10% of spleen) was prepared (32, 42) and analyzed
immediately using anti-B220 and anti-CDllc (41-43) monoclonals to selectively label B and dendritic cells, respectively.
Both B and dendritic cells expressed MHC class II, as well
as several adhesion molecules including ICAM-1/CD54,
LFA-1/CDlla, and pgp-1/CD44; however, only trace levels
of the B7-2 costimulator were detected (Fig. 1, top).
The spleen cells were then separated into adherent and
nonadherent fractions, the former containing most of the den-

dritic cells but some B cells as well, and cultured overnight.
For each of the cultured populations, there was some upregulation in the levels of MHC class II, ICAM-1, LFA-1,
and CD44. However, the increase in B7-2 was particularly
dramatic on dendritic cells (Fig. 1, middle) where the staining
was greater than that seen with anti-MHC class II. Whereas
GL-1 was an IgG2a mAb, and the anti-class II an IgG2b mAb,
the secondary FITC-mouse anti-rat Ig reacted better with
IgG2b than IgG2a primary mAbs as assessed with anti-CD44
mAbs of the two isotypes (data not shown). B7-1 also was
upregulated during culture, but the level of staining with
the isotype-matched 1G10 mAb was <10% of than that seen
with GL-1 anti-B7-2 (data not shown in Fig. 1, but see Fig. 4).
Expression of B7-2 in spleen cells was compared with that
of ceils from several other organs. Peritoneal B cells and macrophages expressed very low levels of B7-2, but substantial
levels of CD54 and CD44 (Fig. 2, PECs). Fresh spleen and
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Figure 2. B7-2 antigen expression is abundant on dendritic calls.
Cell suspensions were prepared from
a variety of different sites as indicated on the x-axis. PECs are freshly
isolated peritoneal cells in which B
cells and macrophages were distinguished by light scattering. Spleen
and lymph node cells were stained
fresh or after culture as in Fig. 1.
B cells were double stained with
B220 mAb, and T cells with antiTCR mAb. Neutrophils (PMNs)
were identified with an R.B6 mAb
in fresh bone marrow. Dendritic
cells were studied from three tissues:
GM-CSF-stimulated marrow cultures as described (34), fresh and cultured spleen low density cells as in
Fig. 1, and epidermal dendritic cells
identified by double labels with antiMH C class II in skin cultures maintained for 0, 1, 2, or 3 d (33).
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Figure 1. B7-2 antigen is upregulated on cultured B cells and dendritic cells. A fraction of spleen
with a low buoyant density, which is enriched in
dendritic cells and activated B cells (32, 42), was
stained with a panel of rat anti-mouse mAbs as
indicated and analyzed on a FACS| The cells were
stained either fresh or after overnight culture. Dendritic cells were identified with an N418 double
label and were the major cell type in the plastic
adherent fraction. B cells were identified with a
B220 double label and were present in both adherent and nonadherent fractions.

Table 1. LPS UpregutatesB7-2 on Macrophagesand B

Lymphocytes, but not Dendritic Cells
Level of B7-2
Cell type
Epidermal
dendritic
cells

C3H/HeN
C3H/HeJ
C3H/HeN
C3H/HeJ

Peritoneal
B cells

C3H/HeN
C3H/HeJ

Expt. 2

+
+

483
ND
481
ND

510
510
487
486

+
+

136
205
132
80

69
121
49
48

+
+

101
211
87
101

63
163
21
27

Three differentcelltypesfromLPSresponsive(C3H/HeN) and nonresponfive (C3H/HeJ) strains were cultured 24 h +- LPS and then analyzed
for B7-2 expressionon the FACS| The mean fluoresxenceof B7-2 on
fresh epidermalisolateswas <40 as in Fig. 2. Data are meanfluorescence
intensity minus background staining with nonreactiveIgG2a antibody
(backgroundwas about 4 for dendriticcells and B cells, and 40 for macrophages). In experiment 1, LPS was at 30 #g/ml whereas in experiment 2, LPS was at 1 #g/ml. In experiment 1, LPS was accidentally
omitted from the dendriticcellcultures(ND), but there was no increase
in B7-2 in companioncultureswith CxD2 F1 epidermaldendriticcells.
lymph node B cells expressed little or no surface B7-2, but
the low density subpopulation of B cells could upregulate
B7-2 upon culture (Fig. 2, B cell adherent and nonadherent
part of histogram). Splenic and lymph node T cells, and bone
marrow neutrophils, had little or no B7-2 (Fig. 2). Dendritic
cells from several different sites could express high levels of
B7-2, but only upon culture (Fig. 2). This was true of dendritic cells from spleen, skin (epidermal Langerhans cells [LCs]
and bone marrow after 7-d growth of precursors using GMCSF as described (34).
We were concerned that sufficient LPS might have been
present in the cultures to upregulate B7-2 expression. Hathcock et al. (44) have shown that LPS upregulates B7-2 expression, and we confirmed this with peritoneal B cells and
macrophages (underlined, Table 1). We chose to study the
LPS-responder and nonresponder strains, C3H/HeN and HeJ,
for B7-2 expression before and after culture. B7-2 was markedly
upregulated (increase in mean fluorescence from <40 to >400)
when either C3H/HeN or C3H/HeJ dendritic cells from
spleen and skin were cultured overnight (Table 1). The FACS|
(Becton Dickinson & Co., Mountain View, CA) signal for
B7-2 on cultured epidermal dendritic cells was 100 x background, and for macrophages, 2-5 x background (Table 1).
In additional experiments, we looked for expression orB7-2
on fresh isolates of leukocytes from blood, marrow, and
1852

Comparison of Dendritic Cell B7-2 Expression with other Surface Molecules, including B7-1. The increase of GL-1 staining
on cultured dendritic cells was monitored in spleen and
epidermal dendritic cells, as in Fig. 2, however, GL-1 staining
was compared to a large panel of other mAbs, including recently isolated hamster mAbs to mouse CD40, CD48, and
CD80/B7-1 (see Materials and Methods). The epitopes recognized by these mAbs, like all of the epitopes seen by the
rat mAbs except for 2D2C anti-CD44 and NLDC-145, were
affected minimally by the level of trypsin that was used to
prepare the epidermal dendritic cells (data not shown). For
the rat mAbs, B7-2 was the accessory molecule that was most
strikingly upregulated during overnight culture (Fig. 3). CD54
or ICAM-1 also increased substantially. HSA, CD44, and
CD45 were upregulated minimally, if at all (CD44 is trypsin
sensitive).
For the hamster mAbs (Fig. 3, bottom), CD40 and B7-1
(mAbs HM40-3 and HMB7) increased in culture, but the
absolute levels were relatively low. CD48, the ligand for mouse
CD2 detected with mAb HM48-1 (40), was not upregulated
on cultured dendritic cells. To compare the extent of staining
with hamster vs rat mAbs, one can use the data with the
hamster and rat anti-MHC class II reagents.
Expression of B7 molecules frequently is assessed using
a fusion protein generated by a construct in which the external domains of CTLA-4 have been fused to the Ig-C domains of human Ig~ (2). CTLA-4 Ig binds to B7-2 and to
B7-1. CTLA-4 binding was markedly upregulated in culture
(Fig. 3, bottom left), confirming the prior work of Larsen et
al. (6). The binding of CTLA-4 Ig closely paralleled binding
of the B7-2 mAb, GL-1.
To further assess the relative expression orB7-1 and B7-2,
we compared staining by FACS| analyses using the 1G10 and
GL-1 isotype-matched mAbs. GL-1 anti-B7-2 staining was
at least 10 times greater than 1G10 anti-B7-1 staining on both
splenic and epidermal dendritic cells (Fig. 4, left). We then
did blocking studies to show that CTLA-4 Ig at 1/~g/ml
totally blocked the binding of B7-2 mAb to dendritic cells,
and B7-2 mAb blocked CTLA-4 binding >90% (Fig. 4,

right).

We conclude that dendritic cells express several adhesion
and costimulatory molecules, but B7-2 appears to be the most
abundant and most dependent upon culture for its upregulation. Given the fact that the immunostimulatory properties
of dendritic cells rise markedly in culture (33, 45, 46), the
results suggest that B7 expression is a critical element of maturation. These findings also emphasized a need to assess the
expression of B7-2 and B7-1 on cells in situ.

Expression of B7-2 in Tissue Sections of Several Nonlymphoid
Organs. The binding of B7-2 to cryostat sections was visual-
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Peritoneal
macrophages

Mouse strain LPS Expt. 1

thymus. Little or no B7-2 staining over the background IgG2a
isotype control was observed, except for a weak level of stain
on the N418 § subset of thymic dendritic cells (43) (which
could increase markedly in culture, data not shown). We conclude that B7-2 is expressed at very low levels on standard
suspensions of freshly isolated mouse leukocytes, but that the
costimulator can be upregulated in culture, particularly on
dendritic cells.
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Figure 3. B7-2 on dendritic cells is abundant relative to other cell surface molecules. Spleen or epidermal dendritic cells were stained with a panel
of mAbs, fresh (day 0), or after 1-3 d in culture. The mAbs (see Materials and Methods) were of rat, hamster, or human ( C T L A 4 - I g )
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ized with a peroxidase F(ab')2 donkey anti-rat Ig. Other
mAbs (see Materials and Methods) were applied to adjacent
sections to localize B cells, T cells, macrophages, and dendritic cells. Shown here are data comparing staining with GL-1
anti-B7-2 with antimacrophage and anti-MHC class II mAbs.
The 1G10 and 16-10A1 anti-B7-1 mAbs did not stain any
of the tissues we studied, even though strong staining was
observed on COS cells transfected with B7-1 cDNA and fixed
similarly to the tissue sections (data not shown).
In liver, GL-1 staining paralleled that seen with antimacrophage and anti-MHC class II mAbs; however, GL-1
staining was weaker (Fig. 5, top). The B7-2 was expressed
by sinusoidal lining profiles, presumably Kupffer cells, the
mononuclear phagocytes of the liver.
In the heart, GL-1 staining again paralleled that seen with
antimacrophage and anti-MHC class II antibodies (Fig. 5,
middle). As in liver, the GL-1 staining was not as strong as
the staining with mAbs to macrophages and M H C class II.
For each mAb, the reactive cells were found in the interstitial
spaces throughout the cardiac muscle. We did not perform
double labeling studies, but prior work by Spencer and Fabre
(47) has shown that in the rat, separate macrophage (MHC
class II weak) and dendritic cell (MHC class II strong) populations occupy the interstitium of rat heart.
In the tongue (Fig. 5, bottom), anti-MHC class II stained
the dendritic cells found in a suprabasal position within the
stratified squamous epithelium (particularly the dorsal aspect
of the tongue shown here). Class II § cells also were found
beneath the epithelium and scattered throughout the interstitial spaces of the tongue muscle. SER-4 antimacrophage
1854
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Figure 4. Relativeexpressionof
the CTLA-4ligandsB7-1and B7-2
on dendriticcells.(Left)2-d cultures
of splenic and epidermal dendritic
cells were stained with a nonreactive antigranulocyteantibody(Gr),
or with 1G10 anti-B7-1 and GL-1
anti-BT-2 mAbs. (Right) Cultures
of epidermal dendritic cells were
stained with GL-1anti-B7-2 in the
presenceof gradeddosesofblocking
CTLA-4 Ig (top) or vice versa
(bottom) to show that B7-2 is the
major CTLA-41gbinding specieson
dendritic cells.

did not stain the stratified squamous epithelium, but did stain
numerous profiles just below the epithelium (Fig. 5, bottom
le~) and throughout the interstitial spaces of the tongue muscle
(data not shown). GL-1 stained a few epithelial dendritic cells
strongly (Fig. 5, bottom), and weakly stained profiles beneath
the epithelium and throughout the muscle, in a distribution
similar to that of the antimacrophage mAb. The findings with
esophagus (data not shown) were similar to those with tongue.
For example, anti-MHC class II stained dendritic cells in the
stratified squamous epithelium, whereas GL-1 anti-B7-2
stained but a few, and SER-4 antimacrophage none. In constrast, submucosal profiles stained strongly with antimacrophage and less strongly with anti-B7-2. Therefore, most dendritic cells in the stratified squamous epithelium have little
B7-2, as is the case in epidermal cell suspensions (Figs. 2 and 3).
In several other organs (data not shown), the profiles that
stained with GL-1 anti-B7-2 were found in the same regions
as SER-4 + macrophages, but the number and intensity of
B7-2 profiles were much less. B7-2 + profiles were noted in
the interstitium of the lung, particularly around vessels and
bronchi, in small numbers in the interstitium of the kidney
and salivary glands, and at the base of the lamina propria
and submucosa of the small intestine. None of the mAbs
(SER-4, GL-1, and M5/114) stained profiles in the brain parenchyma, where microglia are abundant.

Expression of B7-2 in Tissue Sections of Lymphoid Organs.
More abundant staining with GL-1 was noted in lymphoid
relative to nonlymphoid organs, even though suspensions isolated from these organs expressed so little antigen by FACS|
analyses (Fig. 2). Therefore, we suspect that the bulk of the
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Figure 5. Distribution of B7-2 antigen in nonlymphoid tissues. Sections from nonlymphoid organs (liver, heart, and tongue) were stained with the
GL-1 anti-B7-2 mAb (c,f, and i). Adjacent sections were stained with mAbs that help localize B and T cells, macrophages, and dendritic cells. Shown
here on the left is anti-macrophage mAb (FA-11 anti-CD6g [56] for liver or SER-4 antisialoadhesin [39] for heart and tongue) and in the middle,
M5/114 anti MHC class II. In the liver, sinusoidal lining macrophages (arrows) are stained with all three mAbs. In heart, interstitial cells (arrows) are
stained throughout the myocardium. In tongue, SER-4 positive macrophages lie beneath the oral epithelium (arrows), whereas MHC class II positive
dendritic cells are found in a suprabasal location within the epithelium (arrows). GL-1stains occasionalepithelial dendritic cells as shown here (arrows),
and also stains subepithelial profiles weakly.
staining to be described in lymphoid tissues is present on
stromal elements that are difficult to release into suspension
(see Discussion). These B7-2 strong elements were in most
cases confined to regions known to be rich in either macrophages or dendritic cells, as verified by staining adjacent see1855
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tions with appropriate mAbs, e.g., SER-4, FA-11, and F4/80
for macrophages, and NLDC-145 and N418 for dendritic cells
(for an example see reference 42).
In lymph node, GL-1 staining was strong in the subcapsular sinus, a region that is rich in SER-4 + macrophages

Figure 7. (Bottom)Distribution of MHC class II and B7-2 antigens in regions of lymphoid organs that are known to be enriched in dendritic cells.
(a-c) MHC class II stains; (d-J) B7-2 stains. In lymph node (a and d), the T cell area contains the postcapillary venules and many irregular profiles
that stain strongly for MHC class II and B7-2. In spleen (b and e), the T cell area surrounds the central artery (arrow), and stains similarly to lymph
node. In thymus (c and j), MHC class II and B7-2 profiles are in the medulla (M). The cortex (C) contains abundant epithelium that stains for class
II but not B7-2. B7-2 weakly stains scattered cortical profiles (arrow), and these profiles have the same distribution as macrophages.

(compare Fig. 6, a and c, arrowheads). It is interesting to note
that this macrophage-rich region could express relatively little
M H C class II (Fig. 6/~ arrowhead). The B cell follicles stained
with anti-MHC class II, but only weakly for the B7-2 antigen. Dendritic cells are known to be concentrated in the
T cell-rich, deep cortical areas (37, 48-50). These areas contained many dendritic profiles that were rich in both M H C
class II and B7-2, but that lacked macrophage sialoadhesin
(Fig. 6, Fig. 7, a and d).
In spleen, GL-1 again stained certain macrophages strongly,
particularly the marginal metaUophils that surround the white
pulp nodule and are identified with SER-4 in adjacent sections (data not shown). Both M H C class II and B7-2 were
expressed strongly on dendritic profiles in the T cell regions
that occupy the center of the white pulp (Fig. 7, b and e).
These periarterial regions are a known depot of dendritic cells
1856

(37, 42, 49-51). Staining of the B cell follicles for B7-2 was
weak, with the exception of scattered profiles, possibly macrophages (data not shown).
In Peyer's patch (data not shown), GL-1 showed staining
beneath the dome of the epithelium, on scattered profiles in
the B cell follicles, and on many dendritic profiles in the interfollicular T cell areas.
In thymus, a network of abundant B7-2 and M H C class
II antigen was evident in the medulla, the known location
for most thymic dendritic cells (50, 52-54) (Fig. 7, c and
f). B7-2 weak profiles were scattered throughout the cortex
(arrow, Fig. 7f), in a pattern similar to that exhibited by cortical macrophages. M H C class II was abundant on thymic
cortical epithelium, where B7-2 could not be detected (Fig.
7, c and f).
Since isolated leukocytes stained so weakly with GL-1, we

TissueDistribution of the B7-2 Costimulator in Mice

Downloaded from http://rupress.org/jem/article-pdf/180/5/1849/497396/1849.pdf by Rockefeller University user on 21 September 2020

Figure 6. (Tbp)Distribution of B7-2 antigen in lymph node. Sections from lymph node are shown to contrast the distribution of stain with SER-4
antimacrophage, M5/114 MHC class II, and GI:I anti-B7-2. Not shown is the lack of staining with 1G10anti-B7-1. In lymph node, the B cell follicles
and T cell areas are marked, whereas an arrowhead points to the macrophage-rich, subcapsular region.
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considered the possibility that the GL-1 staining in tissue
sections reflected intracelhilar biosynthetic pools rather than
cell surface antigen. To prove that GL-1 was in fact expressed
on the surface of macrophages and dendritic cells in situ, we
injected 50/xg of GL-1 Ig intravenously and 50/~g of a nonreactive IgG2a mAb. 16 h later, the spleens were removed
for sectioning and staining with anti-Ig. No staining was
seen if control IgG2a had been injected, but after GL-1 injection, the antibody was distributed in a pattern identical to
that seen with direct application of GL-1 to sections, and
nearly as strong (data not shown). Therefore, the B7-2 antigen is very likely to be expressed at the cell surface to be
able to selectively trap the corresponding monoclonal, GL-1.
Blocking Dendritic Cell Function at the Level of the B7 Costimulator System. T cell responses to B7-2-bearing APCs were
monitored with three different types ofligands for the TCR
(allogeneic and syngeneic MHC, the Mls-1 ~ superantigen,
and anti-CD3). GL-1 anti-B7-2 significantly reduced stimulation by both dendritic cells and B blasts over a broad range
of APC doses (Fig. 8). The block of dendritic cell function
in four experiments ranged from 35 to 65% and was comparable using doses of 1 to 5 #g/ml. 1G10 anti-B7-1 exerted
a weak blocking effect and this was additive when 1G10 and
GL-1 were tested together. Likewise, CTLA-4 Ig blocked
T cell stimulation better than anti-B7-2, and CTLA-4 would
be expected to block both B7-1 and B7-2 costimulators (Fig. 8).
When IL-2 production was measured (data not shown),
we again observed a much better block with GL-1 anti-B7-2
(~70%) than 1G10 anti-B7-1 (~20%), and that CTLA-4
Ig blocked better than GL-1. We conclude that B7-2 is the
most prevalent CTLA-4/CD28 ligand on dendritic cells and
accounts for the costimulation provided by this pathway during
several in vitro immune responses.
Discussion

Prior work has shown that dendritic cells in certain sites
are immunologically immature, i.e., the cells do not act as
1857
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potent APCs for several T cell responses. Functional immaturity is evident in dendritic cells isolated from mouse spleen
(43) and skin (33, 45, 46), and from human blood (30). Potent T cell stimulatory function rapidly develops when the
dendritic ceils are cultured, most likely the result ofcytokines,
particularly GM-CSF (45, 46) but also IL-1 (46, 55). Since
GM-CSF is made by made by many cell types, e.g., the keratinocytes of the skin (45), it is possible that whenever one
dissociates a tissue, sufficient GM-CSF is released to trigger
the maturation of dendritic cells that are subsequently placed
in culture.
Recent work (44) has described the regulated expression
of B7-2, a newly recognized costimulator of IL-2 production (see Introductory section). B7-2 expression is induced
on B cells by LPS or by anti-Ig, and on macrophages by LPS
or by IFN-% Here we have focused on dendritic cells. B7-2
is difficult to detect on freshly isolated dendritic cells but when
placed in culture, B7-2 increases dramatically, much more
than on any other leukocyte (Figs. 1-3). The levels of B7-2
appear to be as high or even higher than most other known
surface components of the dendritic cell including the HSA,
pgp/CD44, leukocyte common antigen/CD45, LFA-3 analogue/CD48, ICAM-1/CD54, and even MHC class II (Fig. 3).
The factors that regulate B7-2 on dendritic cells remain
to be identified. We have achieved only partial decreases in
B7-2 by applying anti-GM-CSF antibodies to skin cultures
but as mentioned, the requisite cytokines may have been
released during the preparation of the skin cells. LSP however, does not seem to upregulate B7-2 expression as occurs
with macrophages and B cells (Table 1, and 44). Likewise,
dendritic cells upregulate B7-2 to a much greater extent than
other APCs, when cells are placed in culture. Therefore, the
control of B7-2 expression in dendritic cells seems to differ
from the controls in other APCs.
B7-1 expression, as assessed by 1G10 rat and HMB7 hamster mAbs, also is upregulated on spleen and skin dendritic
cells in culture, but the levels of staining are much lower than
with antibody to B7-2 (Figs. 3 and 4). B7-2 accounts for

Downloaded from http://rupress.org/jem/article-pdf/180/5/1849/497396/1849.pdf by Rockefeller University user on 21 September 2020

Q
r

Figure 8. Blocking effects of
GL-1 mAb on T cell proliferative
responses to dendritic cells or LPSinduced B blasts. C57BL/6 x
DBA/2 F1 (H-2 bxd) APCs were
irradiated and used to stimulate syngeneic T cells (syn MLR), MHCdisparate BALB/c x DBA/2 F1
(H-2 dxd) T cells (AIIo-MLR),
Mls-1 disparate BALB/c x C57BL/6
T cells (Mls), or syngeneic T cells
in the presence of 2 C l l anti-CD3
mAb. Shown here are data with two
doses of APCs in the absence of
blocking mAb or in the presence of
control rat IgG2a, G b l anti-B7-2,
1G10 anti-B7-1, CTLA-4 Ig, and
CD7 lg, each at 1 #g/m1. D N A
synthesis was used as the measure
of the T cell response.

Beginning with the studies of Linsley et al. (2), a good
deal of evidence has implicated CD28/CTLA-4 ligands in
the control of IL-2 production. Hathcock et al. (44) recently
showed that GL-1 anti-B7-2 did not block induction of the
IL-2 receptor in stimulated T cells, but greatly reduced IL-2
synthesis. For dendritic cells, the block of dendritic cell function by anti-B7-2 reagents is incomplete (Fig. 8). It has been
consistently observed that mAbs to a single accessory molecule on dendritic cells fail to exert a total block of APC function (29). Part of the difficulty may relate to the high levels
of expression of these ligands on dendritic cells, but most
likely, each of the accessory molecules are playing significant
roles in initiating IL-2 production and DNA synthesis in T
cells.
Whereas the potency and other properties of different APCs
(B cells, macrophages, and dendritic ceils) are distinct, qualitative differences in the expression of many adhesion and
costimulator molecules have yet to be encountered. For example, CDlla, CD44, CD54, CD48/58, CD80, and B7-2
all can be expressed on each of these APCs. What does appear to differ are the relative levels of the accessory molecules
and the regulation of this expression. The mean fluorescence
intensity of the B7-2 stain on cultured splenic dendritic cells
is much higher than that on B cells, including B cells stimulated 24 h with LPS or anti-IgM, or on peritoneal macrophages, including macrophages stimulated with LPS or IFN-',/
(e.g., Table 1, Fig. 1). As mentioned, the upregulation of
B7-2 on cultured epidermal dendritic cells takes place within
16 h in culture, is long lasting (at least 3 d in our studies;
Figs. 2 and 3); and occurs without any additions to the
medium. LPS does not seem responsible, since upregulation
takes place equally well in LPS-unresponsive and -responsive,
C3H/HeJ and C 3 H / H e N strains. Therefore, many accessory
molecules do not vary qualitatively amongst different APCs,
but there are differences relating to content and cues. The
dendritic cell is posed to upregulate many accessory molecules, and to high levels and for prolonged periods, upon minimal provocation.
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